Literature DB >> 36074173

Bioactive extracellular matrix fragments in tendon repair.

Ritika Mohindra1, Rohit Mohindra1, Devendra K Agrawal1, Finosh G Thankam2.   

Abstract

Tendinopathy is a common tendon disorder that causes pain, loss of strength and function, and local inflammation mainly characterized by hypoxia, collagen degradation, and extracellular matrix (ECM) disorganization. Generally, ECM degradation and remodeling is tightly regulated; however, hyperactivation of matrix metalloproteases (MMPs) contributes to excessive collagenolysis under pathologic conditions resulting in tendon ECM degradation. This review article focuses on the production, function, and signaling of matrikines for tendon regeneration following injury with insights into the expression, tissue compliance, and cell proliferation exhibited by various matrikines. Furthermore, the regenerative properties suggest translational significance of matrikines to improve the outcomes post-injury by assisting with tendon healing.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  MMPs; Matricryptins; Matrikines; Matrix degradation fragments; Tendinopathy; Tendon regeneration

Year:  2022        PMID: 36074173     DOI: 10.1007/s00441-022-03684-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   4.051


  79 in total

Review 1.  Fibrocartilage in tendons and ligaments--an adaptation to compressive load.

Authors:  M Benjamin; J R Ralphs
Journal:  J Anat       Date:  1998-11       Impact factor: 2.610

2.  Advantages of RGD peptides for directing cell association with biomaterials.

Authors:  Susan L Bellis
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

3.  Fibrocartilage associated with human tendons and their pulleys.

Authors:  M Benjamin; S Qin; J R Ralphs
Journal:  J Anat       Date:  1995-12       Impact factor: 2.610

4.  Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial.

Authors:  Håkan Alfredson; Lars Ohberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-02-02       Impact factor: 4.342

5.  Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study.

Authors:  Steven P Arnoczky; Michael Lavagnino; Monika Egerbacher; Oscar Caballero; Keri Gardner
Journal:  Am J Sports Med       Date:  2007-02-09       Impact factor: 6.202

Review 6.  Tendon basic science: Development, repair, regeneration, and healing.

Authors:  Nelly Andarawis-Puri; Evan L Flatow; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2015-04-24       Impact factor: 3.494

7.  High patient satisfaction after arthroscopic subacromial decompression for shoulder impingement: a prospective study of 50 patients.

Authors:  Marie Bengtsson; Karl Lunsjö; Ylva Hermodsson; Anders Nordqvist; Fikri M Abu-Zidan
Journal:  Acta Orthop       Date:  2006-02       Impact factor: 3.717

8.  A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

Authors:  Lindsay B Alcaraz; Aude Mallavialle; Timothée David; Danielle Derocq; Frédéric Delolme; Cindy Dieryckx; Caroline Mollevi; Florence Boissière-Michot; Joëlle Simony-Lafontaine; Stanislas Du Manoir; Pitter F Huesgen; Christopher M Overall; Sophie Tartare-Deckert; William Jacot; Thierry Chardès; Séverine Guiu; Pascal Roger; Thomas Reinheckel; Catherine Moali; Emmanuelle Liaudet-Coopman
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

Review 9.  Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models.

Authors:  Sunny Akogwu Abbah; Kyriakos Spanoudes; Timothy O'Brien; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Stem Cell Res Ther       Date:  2014       Impact factor: 6.832

10.  Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome.

Authors:  T Bachelot; D Ratel; C Menetrier-Caux; D Wion; J-Y Blay; F Berger
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.